🔎 Trials Near Me

Utama › Penyakit Sel Sabit › Connecticut

Kajian klinikal Penyakit Sel Sabit di Connecticut

7 kajian untuk Penyakit Sel Sabit sedang mencari peserta di lokasi di Connecticut.

Bandar di Connecticut

Teks kajian rasmi (Bahasa Inggeris)

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

  • Yale-New Haven Hospital, New Haven
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT06481306

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

  • Connecticut Children's Medical Center, Hartford
  • Smilow Cancer Hospital, New Haven
Mengambil pesertaFasa 2/3
Umur 12 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT05431088

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Connecticut Children's Medical Center, Hartford
  • Yale Hemophilia Treatment Center, New Haven
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

  • Yale School of Medicine, New Haven
Mengambil pesertaFasa 1/2
1 Day – 21 Years · Semua jantina · Dikemas kini 29 Mei 2026 · NCT03128996

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

  • Connecticut Children's Medical Center, Hartford
Mengambil peserta
Umur 16 hingga 30 · Semua jantina · Dikemas kini 7 Jan 2026 · NCT06374238

Integrative Training Program for Pediatric Sickle Cell Pain

  • Connecticut Children's Medical Center, Hartford
Mengambil peserta
Umur 12 hingga 18 · Semua jantina · Dikemas kini 14 Nov 2025 · NCT06691867

Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait

  • UConn Health, Farmington
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 50 ke atas · Wanita · Dikemas kini 24 Jul 2025 · NCT07083531

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.